Me is to cut 200 jobs in the wake of declining revenues. This company expects a proposed retructuring, affecting 40% of its ...

23andMe, the struggling ancestry tracing company, continues to spiral, raising questions about its business prospects and what could happen to its sensitive customer genetic testing data. CEO Anne ...

Meanwhile, Hims & Hers tackles the GLP-1 shortage with a new app; Eli Lilly releases data on tirzepatide efficacy; 23andMe faces privacy concerns; and more.

What is the most Silicon Valley thing about your morning routine? Zoë, you go first. Zoë Schiffer: Pretty much the first ...

o. 23andMe is considered a direct-to-consumer genetic testing company, and transactions with the company are considered ...

The financial struggles of genetic testing and ancestry company 23andMe are raising questions about the security of customers ...

Concerns about 23andMe's business prospects is raising questions about the genetic testing company's customer data.

On Tuesday, direct-to-consumer genetic testing firm 23andMe announced it would be shuttering its much-hyped drug development ...

Home genetics company 23andMe continues to struggle as demand for casual gene tracing declines. On Monday, the company announced that it has decided on a restructuring ...

American chief executive Robert Isom and JetBlue president Marty St. George on Tuesday each hinted that a new partnership was ...

Me announced on Monday it would cut 40% of its workforce, representing more than 200 employees, as part of a restructuring at ...